Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease (Q41376875)

30 September 2017

1 reference

title

Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease (English)

1 reference

30 September 2017

0 references

Yamada K

1

1 reference

30 September 2017

Nitta A

2

1 reference

30 September 2017

Hasegawa T

3

1 reference

30 September 2017

Fuji K

4

1 reference

30 September 2017

Hiramatsu M

5

1 reference

30 September 2017

Kameyama T

6

1 reference

30 September 2017

Furukawa Y

7

1 reference

30 September 2017

Hayashi K

8

1 reference

30 September 2017

Nabeshima T

9

1 reference

30 September 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

Behavioural Brain Research

30 September 2017

1 reference

30 September 2017

83

1 reference

30 September 2017

1-2

1 reference

30 September 2017

117-122

1 reference

Remote astrocytic response of prefrontal cortex is caused by the lesions in the nucleus basalis of Meynert, but not in the ventral tegmental area.

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Increase in glia-derived nerve growth factor following destruction of hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

General and dramatic glial reaction in Alzheimer brains

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Effects of repeated administration of propentofylline on memory impairment produced by basal forebrain lesion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

A highly sensitive enzyme immunoassay for mouse beta nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

NGF-Mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: Evidence for a physiological role of NGF in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Nerve growth factor (NGF) stimulation of cholinergic telencephalic neurons in aggregating cell cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Developments of a water-maze procedure for studying spatial learning in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

NGF level of is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Oral administration of NGF synthesis stimulators recovers reduced brain NGF content in aged rats and cognitive dysfunction in basal-forebrain-lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Oral administration of idebenone, a stimulator of NGF synthesis, recovers reduced NGF content in aged rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Effects of oral administration of a stimulator for nerve growth factor synthesis in basal forebrain-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Memory impairment and neural dysfunction after continuous infusion of anti-nerve growth factor antibody into the septum in adult rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Oral administration of idebenone induces nerve growth factor in the brain and improves learning and memory in basal forebrain-lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Quantitative autoradiography of muscarinic cholinergic receptors in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Effects of nerve growth factor (NGF) in rats with basal forebrain lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Habituation of exploratory activity in mice: a screening test for memory enhancing drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Stimulation of nerve growth factor synthesis/secretion by 1,4-benzoquinone and its derivatives in cultured mouse astroglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Disposition of idebenone (CV-2619), a new cerebral metabolism improving agent, in rats and dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

Further studies on the inhibition of adenosine uptake into rat brain synaptosomes by adenosine derivatives and methylxanthines

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2897%2986054-8

7 January 2021

10.1016/S0166-4328(97)86054-8

Identifiers

DOI

1 reference

30 September 2017

1 reference